D. E. Shaw & Co »

Tscan Therapeutics shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2026-03-31 $323k 320k 1.01
2025-12-31 $69k 69k 1.00

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom Call Option (AVGO)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl C Call Option (GOOG)
Micron Technology Put Option (MU)
Meta Platforms Cl A Call Option (META)
Amazon (AMZN)
Boston Scientific Corporation Call Option (BSX)
Advanced Micro Devices Put Option (AMD)
Taiwan Semiconductor Manufac Sponsored Ads Call Option (TSM)
JPMorgan Chase & Co. Call Option (JPM)
Palantir Technologies Cl A Call Option (PLTR)

View all positions for D. E. Shaw & Co

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
BVF
Baker Bros. Advisors
Vanguard Group
Vanguard Capital Management
BlackRock
Millennium Management
Deer Management
Two Sigma Investments
Renaissance Technologies
Standard Life Aberdeen
Jacobs Levy Equity Management
DC Funds
Geode Capital Management
GSA Capital Partners

View all funds holding Tscan Therapeutics